A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.
MOTS-C 2mg/mL
Investigational Mitochondrial-Derived Peptide
Compound Specifications
MOTS-C 2mg/mL
Investigational Mitochondrial-Derived Peptide
MOTS-C is a mitochondrial-derived peptide encoded in the 12S rRNA gene that has been investigated in preclinical research for its potential interactions with metabolic homeostasis, AMPK signaling pathways, and fatty acid oxidation in skeletal muscle. This is an investigational compound; these statements have not been evaluated by the FDA and it is not intended to diagnose, treat, cure, or prevent disease.
In laboratory research models, MOTS-C has been studied for potential activation of AMPK (adenosine monophosphate-activated protein kinase) and interactions with cellular metabolic signaling pathways. Results may vary; individual outcomes depend on baseline health, adherence, and other factors.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Administer subcutaneously prior to workouts or fasting windows.
Frequently Asked Clinical Questions
Why is MOTS-C called an 'exercise in a vial'?
Preclinical research has explored MOTS-C for potential AMPK pathway interactions that overlap with cellular signals observed during exercise. This is investigational research only; results may vary and individual outcomes depend on baseline health and other factors.